Psychedelics will soon be treating a mental health patient near you. The quality and breadth of clinical data that has already emerged, coupled with ever-increasing regulatory and political acceptance – along with enormous need in the mental health space – mean that it is now only a matter of time before these compounds start to […]

The post The Pharma Letter – The psychedelic medicine renaissance: how could the route to market play out? appeared first on Psychedelics Today.

Previous articleEnosis Therapeutics announces its response to Australian TGA decision, Plans to Present at SXSW 2023
Next articleFierce Healthcare – Psychedelics Today to offer yearlong certificate course on psychedelic therapy